Isoproterenol Pregnancy and Breastfeeding Warnings
Medically reviewed by Drugs.com. Last updated on Sep 27, 2022.
Isoproterenol is also known as: Isuprel, Isuprel Mistometer, Medihaler-Iso
Isoproterenol Pregnancy Warnings
Animal studies have not been reported. There are no controlled data in human pregnancy.
AU TGA pregnancy category A: Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
This drug should be used during pregnancy only if clearly needed and the benefit outweighs the risk.
AU TGA pregnancy category: A
US FDA pregnancy category: C
Isoproterenol Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
See also
References for pregnancy information
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Isuprel HCl (isoproterenol)." Hospira Inc (2017):
References for breastfeeding information
- Cerner Multum, Inc. "Australian Product Information." O 0
- "Product Information. Isuprel HCl (isoproterenol)." Hospira Inc (2017):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.